DCGI's New Code for Drug Inspectors Focuses on Market Vigil and Regulatory Improvements
DCGI Issues Fresh Code for Drug Inspectors
The Drugs Controller General of India (DCGI) has introduced a new code for drug inspectors, designed to make inspections and sample collections more uniform and predictable. As of September 12, these updated guidelines are set to enhance the regulatory system concerning drug, cosmetic, and medical device safety.
Key Updates in the Drug Inspector Code
- Uniform Sampling Method: Drug inspectors must now adhere to a standardized sampling method, ensuring better identification of risks.
- Monthly Sampling Plans: Each inspector, in consultation with their authority, will create a monthly sampling plan that includes rural areas and regions with endemic diseases.
- Centralized Monitoring: A monthly list of sub-standard drugs will be maintained publicly to ensure accountability.
This initiative aims to effectively monitor the quality of drugs and cosmetics while ensuring compliance with Good Manufacturing Practices (GMP) standards. The move to replace the outdated guidelines reflects a commitment to advancing the regulatory framework while addressing the critical shortage of drug inspectors and enhancing public health safety.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.